Answers are grounded in this paper and cite their sources.
AMH is the best current available measure of ovarian reserve for different clinical conditions. However, prospective well powered studies comparing different infertility treatment strategies based on initial AMH levels using appropriate end-points, such as live birth and cost-effectiveness, are urgently awaited. Such studies could represent a true step forward in rendering counseling and infertility care more patient tailored.
No takes yet. Share an insight, caveat, or question.
Broer et al. (2014) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: